Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Swati Venkat

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Cancers|February 10, 2024
Alternative Polyadenylation Characterizes Epithelial and Fibroblast Phenotypic Heterogeneity in Pancreatic Ductal AdenocarcinomaSwati Venkat, Michael E Feigin
Molecular Biology of the Cell|August 4, 2017
Manganese-induced trafficking and turnover of GPP130 is mediated by sortilinSwati Venkat, Adam D Linstedt
Trends in Cancer|February 23, 2021
Drivers of Gene Expression Dysregulation in Pancreatic CancerSwati Venkat, Abdulrahman A Alahmari, Michael E Feigin
Molecular Cancer Research : MCR|August 24, 2022
Regulation of Cyclin D1 Degradation by Ubiquitin-Specific Protease 27X Is Critical for Cancer Cell Proliferation and Tumor GrowthShamshad Alam, Amanda Zunic, Swati Venkat, et al.
United European Gastroenterology Journal|February 19, 2025
Serum Collagen Biomarkers Are Reflective of Tissue Specific Fibroblasts Associated With Ulcerative Colitis Activity and Treatment Response to UstekinumabSwati Venkat, Joshua Rusbuldt, Dylan Richards, et al.
Genome Research|February 8, 2020
Alternative polyadenylation drives oncogenic gene expression in pancreatic ductal adenocarcinomaSwati Venkat, Arwen A Tisdale, Johann R Schwarz, et al.
Journal of Crohn'S & Colitis|November 19, 2025
Serum protein profiles differ with adalimumab and ustekinumab treatment in moderately to severely active Crohn's diseaseSwati Venkat, Martha Zeeman, Amy Hart, et al.
Science Advances|September 2, 2022
Endogenous DOPA inhibits melanoma through suppression of CHRM1 signalingMiriam Doepner, Inyoung Lee, Christopher A Natale, et al.
RNA (New York, N.Y.)|January 8, 2024
CPSF3 inhibition blocks pancreatic cancer cell proliferation through disruption of core histone mRNA processingAbdulrahman A Alahmari, Aditi H Chaubey, Venkata S Jonnakuti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 17, 2023
Lorazepam Stimulates IL6 Production and Is Associated with Poor Survival Outcomes in Pancreatic CancerAbigail C Cornwell, Arwen A Tisdale, Swati Venkat, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Cancers|February 10, 2024
Alternative Polyadenylation Characterizes Epithelial and Fibroblast Phenotypic Heterogeneity in Pancreatic Ductal AdenocarcinomaSwati Venkat, Michael E Feigin
Molecular Biology of the Cell|August 4, 2017
Manganese-induced trafficking and turnover of GPP130 is mediated by sortilinSwati Venkat, Adam D Linstedt
Trends in Cancer|February 23, 2021
Drivers of Gene Expression Dysregulation in Pancreatic CancerSwati Venkat, Abdulrahman A Alahmari, Michael E Feigin
Molecular Cancer Research : MCR|August 24, 2022
Regulation of Cyclin D1 Degradation by Ubiquitin-Specific Protease 27X Is Critical for Cancer Cell Proliferation and Tumor GrowthShamshad Alam, Amanda Zunic, Swati Venkat, et al.
United European Gastroenterology Journal|February 19, 2025
Serum Collagen Biomarkers Are Reflective of Tissue Specific Fibroblasts Associated With Ulcerative Colitis Activity and Treatment Response to UstekinumabSwati Venkat, Joshua Rusbuldt, Dylan Richards, et al.
Genome Research|February 8, 2020
Alternative polyadenylation drives oncogenic gene expression in pancreatic ductal adenocarcinomaSwati Venkat, Arwen A Tisdale, Johann R Schwarz, et al.
Journal of Crohn'S & Colitis|November 19, 2025
Serum protein profiles differ with adalimumab and ustekinumab treatment in moderately to severely active Crohn's diseaseSwati Venkat, Martha Zeeman, Amy Hart, et al.
Science Advances|September 2, 2022
Endogenous DOPA inhibits melanoma through suppression of CHRM1 signalingMiriam Doepner, Inyoung Lee, Christopher A Natale, et al.
RNA (New York, N.Y.)|January 8, 2024
CPSF3 inhibition blocks pancreatic cancer cell proliferation through disruption of core histone mRNA processingAbdulrahman A Alahmari, Aditi H Chaubey, Venkata S Jonnakuti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 17, 2023
Lorazepam Stimulates IL6 Production and Is Associated with Poor Survival Outcomes in Pancreatic CancerAbigail C Cornwell, Arwen A Tisdale, Swati Venkat, et al.
Pageof 2